ADCETRIS + AVD in first-line treatment of Stage III/IV cHL ~ 8/11/21 @6PM ~ LIVEJun 25, 20211 min readTo RSVP, please reach out to your Seagen Account Manager, Carrie Maricic at cmaricic@seagen.com by email or by phone at (603) 339-3451.August 11th 20.pdfDownload PDF • 2.34MB
NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress
NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!
Comments